Global Insider: NGOs Push Public Health Interests in Trade Negotiations

Global Insider: NGOs Push Public Health Interests in Trade Negotiations

As negotiations continue on the Trans-Pacific Partnership (TPP) trade agreement, one persistent sticking point has been public health, and in particular patent protections for pharmaceuticals. In an email interview, Frederick M. Abbott, the Edward Ball Eminent Scholar at Florida State University College of Law and an expert on international intellectual property rights, explained the public health concerns involved in trade negotiations.

WPR: In what ways have public health issues arisen as points of contention in the current rounds of major multilateral trade talks, such as the Trans-Pacific Partnership?

Frederick M. Abbott: Issues relating to public health are perhaps the major source of contention in the TPP negotiations, following a trend that has characterized many sets of bilateral and regional trade negotiations since the end of the Uruguay Round. Negotiations regarding public health subjects have largely shifted to “plurilateral” forums because establishing a broad consensus on these subjects is typically very difficult.

Keep reading for free!

Get instant access to the rest of this article by submitting your email address below. You'll also get access to three articles of your choice each month and our free newsletter:

Or, Subscribe now to get full access.

Already a subscriber? Log in here .

What you’ll get with an All-Access subscription to World Politics Review:

A WPR subscription is like no other resource — it’s like having a personal curator and expert analyst of global affairs news. Subscribe now, and you’ll get:

  • Immediate and instant access to the full searchable library of tens of thousands of articles.
  • Daily articles with original analysis, written by leading topic experts, delivered to you every weekday.
  • Regular in-depth articles with deep dives into important issues and countries.
  • The Daily Review email, with our take on the day’s most important news, the latest WPR analysis, what’s on our radar, and more.
  • The Weekly Review email, with quick summaries of the week’s most important coverage, and what’s to come.
  • Completely ad-free reading.

And all of this is available to you when you subscribe today.